BOSSI, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 2923
EU - Europa 1973
AS - Asia 1503
SA - Sud America 240
OC - Oceania 217
AF - Africa 108
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6966
Nazione #
US - Stati Uniti d'America 2778
IT - Italia 631
CN - Cina 357
IN - India 283
FR - Francia 217
DE - Germania 210
AU - Australia 206
GB - Regno Unito 180
JP - Giappone 169
SE - Svezia 163
BR - Brasile 154
IL - Israele 118
CA - Canada 109
TR - Turchia 100
ES - Italia 96
TW - Taiwan 75
IE - Irlanda 73
HK - Hong Kong 67
PL - Polonia 49
NL - Olanda 47
VN - Vietnam 42
CH - Svizzera 41
KR - Corea 40
IR - Iran 39
MY - Malesia 37
ZA - Sudafrica 37
CL - Cile 34
TH - Thailandia 34
RU - Federazione Russa 31
CZ - Repubblica Ceca 30
RO - Romania 30
EG - Egitto 28
ID - Indonesia 27
MX - Messico 27
PK - Pakistan 21
PT - Portogallo 21
SG - Singapore 21
BE - Belgio 20
GR - Grecia 20
SA - Arabia Saudita 19
CO - Colombia 17
NO - Norvegia 15
AT - Austria 14
DK - Danimarca 13
PE - Perù 13
PH - Filippine 11
HR - Croazia 10
NZ - Nuova Zelanda 9
BD - Bangladesh 8
FI - Finlandia 8
HU - Ungheria 8
BG - Bulgaria 7
IQ - Iraq 7
UY - Uruguay 7
AR - Argentina 6
LT - Lituania 6
MK - Macedonia 6
UA - Ucraina 6
DZ - Algeria 5
KE - Kenya 5
RS - Serbia 5
SI - Slovenia 5
VE - Venezuela 5
GH - Ghana 4
IS - Islanda 4
JO - Giordania 4
LY - Libia 4
MA - Marocco 4
NP - Nepal 4
SY - Repubblica araba siriana 4
BT - Bhutan 3
EC - Ecuador 3
JM - Giamaica 3
KG - Kirghizistan 3
MW - Malawi 3
SD - Sudan 3
SN - Senegal 3
TN - Tunisia 3
BY - Bielorussia 2
ET - Etiopia 2
EU - Europa 2
LB - Libano 2
MM - Myanmar 2
MN - Mongolia 2
PG - Papua Nuova Guinea 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TZ - Tanzania 2
AL - Albania 1
AN - Antille olandesi 1
BO - Bolivia 1
CR - Costa Rica 1
ER - Eritrea 1
KW - Kuwait 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
MU - Mauritius 1
NI - Nicaragua 1
OM - Oman 1
Totale 6961
Città #
Houston 195
Fairfield 170
Ashburn 145
Stockholm 142
Seattle 94
Woodbridge 87
Ann Arbor 71
Chicago 68
Brescia 65
Dublin 64
Buffalo 57
Palaiseau 57
Taipei 54
Cambridge 50
Melbourne 48
Wilmington 47
Shanghai 46
Rome 43
Beijing 42
Milan 42
Bengaluru 36
Fleming Island 33
Los Angeles 33
Paris 33
Dong Ket 30
New York 30
San Diego 30
Central District 29
Warsaw 29
Nuremberg 28
Tokyo 28
Guangzhou 27
Hyderabad 27
Ottawa 26
Chengdu 25
Delhi 24
Boardman 23
Hefei 23
Jerusalem 22
Mumbai 21
Bangkok 19
Sydney 19
São Paulo 19
Istanbul 18
Dallas 17
Des Moines 17
Las Vegas 17
Nanjing 17
San Francisco 17
Brisbane 16
London 16
Tel Aviv 16
Turin 16
Adelaide 15
Berlin 15
Brooklyn 15
Hamburg 15
Kumar 15
Toronto 15
Ankara 14
Atlanta 14
Central 14
Gurgaon 14
San Antonio 14
Chiba 13
Frankfurt am Main 13
Henderson 13
Manchester 13
Santiago 13
Changsha 12
Fortaleza 12
Madrid 12
Mexico City 12
Muizenberg 12
Pune 12
Athens 11
Cape Town 11
Hangzhou 11
Jakarta 11
Lima 11
Padova 11
Philadelphia 11
Redmond 11
Seoul 11
Singapore 11
Azzano San Paolo 10
Cedar Knolls 10
Clermont-Ferrand 10
Izmir 10
Lake Forest 10
Rochester 10
Verona 10
Boston 9
Boydton 9
Cairo 9
Campinas 9
Chongqing 9
Kuala Lumpur 9
Phoenix 9
Southampton 9
Totale 2917
Nome #
Systematic review of photobiomodulation for the managementof oral mucositis in cancer patients and clinical practice guidelines, file ddc633e3-cc0b-4e2e-e053-3705fe0a4c80 1967
Systematic review of natural and miscellaneous agents, for the management of oral mucositis in cancer patients and clinical practice guidelines - part 2: honey, herbal compounds, saliva stimulants, probiotics, and miscellaneous agents, file ddc633e3-fd32-4e2e-e053-3705fe0a4c80 910
The 8th TNM classification for oral squamous cell carcinoma: What is gained, what is lost, and what is missing, file ddc633e4-1344-4e2e-e053-3705fe0a4c80 648
Malignant tumors of the maxillary sinus: Prognostic impact of neurovascular invasion in a series of 138 patients, file ddc633e4-04ea-4e2e-e053-3705fe0a4c80 492
Cohort analysis of safety and efficacy of vismodegib in Italian patients from the Phase II, multicenter STEVIE study, file ddc633e4-1e66-4e2e-e053-3705fe0a4c80 418
Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma, file ddc633e4-30fb-4e2e-e053-3705fe0a4c80 275
Tumor biomarkers for the prediction of distant metastasis in head and neck squamous cell carcinoma, file ddc633e4-1d97-4e2e-e053-3705fe0a4c80 117
Prognostic Nomograms in Oral Squamous Cell Carcinoma: The Negative Impact of Low Neutrophil to Lymphocyte Ratio, file ddc633e3-c6a4-4e2e-e053-3705fe0a4c80 113
Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant Lesions, file ddc633e4-1342-4e2e-e053-3705fe0a4c80 101
Clinical and histological prognostic factors of recurrent and/or metastatic salivary gland adenoid cystic carcinoma, file ddc633e4-25a9-4e2e-e053-3705fe0a4c80 95
Gene expression profiling to improve prognostic characterization of olfactory neuroblastoma and to define new targetable pathways, file ddc633e4-24c2-4e2e-e053-3705fe0a4c80 94
Systematic review of natural and miscellaneous agents for the management of oral mucositis in cancer patients and clinical practice guidelines-part 1: vitamins, minerals, and nutritional supplements., file ddc633e3-ed12-4e2e-e053-3705fe0a4c80 87
Role of IMRT/VMAT-Based Dose and Volume Parameters in Predicting 5-Year Local Control and Survival in Nasopharyngeal Cancer Patients, file ddc633e4-2648-4e2e-e053-3705fe0a4c80 76
Gene expression profiling of olfactory neuroblastoma helps identify prognostic pathways and define potentially therapeutic targets, file ddc633e4-4fbd-4e2e-e053-3705fe0a4c80 74
Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma, file ddc633e4-3436-4e2e-e053-3705fe0a4c80 72
Digital health for optimal supportive care in oncology: benefits, limits, and future perspectives, file ddc633e4-5bdc-4e2e-e053-3705fe0a4c80 66
Addressing the quality of life needs of older patients with cancer: A SIOG consensus paper and practical guide, file ddc633e4-6673-4e2e-e053-3705fe0a4c80 66
Assessing Preferences in Patients with Head and Neck Squamous Cell Carcinoma: Phase I and II of Questionnaire Development, file ddc633e4-20b4-4e2e-e053-3705fe0a4c80 61
Diarrhoea in adult cancer patients: ESMO Clinical Practice Guidelines, file ddc633e4-6393-4e2e-e053-3705fe0a4c80 61
The efficacy of immunonutrition in improving tolerance to chemoradiotherapy in patients with head and neck cancer, receiving nutritional counseling: study protocol of a randomized, open-label, parallel group, bicentric pilot study, file ddc633e4-671b-4e2e-e053-3705fe0a4c80 56
A ct-based radiomic signature can be prognostic for 10-months overall survival in metastatic tumors treated with nivolumab: An exploratory study, file ddc633e4-6279-4e2e-e053-3705fe0a4c80 55
The association between Vitamin D and gut microbiota: A systematic review of human studies, file ddc633e4-5a6c-4e2e-e053-3705fe0a4c80 54
Regional disease in head and neck cutaneous squamous cell carcinoma: the role of primary tumor characteristics and number of nodal metastases, file ddc633e4-5670-4e2e-e053-3705fe0a4c80 53
The use of fentanyl in pain management in head and neck cancer patients: a narrative review, file ddc633e4-631c-4e2e-e053-3705fe0a4c80 53
Prognostic significance of cd4+ and cd8+ tumor-infiltrating lymphocytes in head and neck squamous cell carcinoma: A meta-analysis, file ddc633e4-3e08-4e2e-e053-3705fe0a4c80 52
Patterns of recurrences in sinonasal cancers undergoing an endoscopic surgery-based treatment: Results of the MUSES* on 940 patients: *MUlti-institutional collaborative Study on Endoscopically treated Sinonasal cancers, file acdf5aa5-000b-4078-a1df-0fbbc527132d 49
Prognostic value of H-index in patients surgically treated for squamous cell carcinoma of the larynx, file ddc633e4-5de6-4e2e-e053-3705fe0a4c80 45
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic, file ddc633e4-6246-4e2e-e053-3705fe0a4c80 45
Sinonasal squamous cell carcinoma, a narrative reappraisal of the current evidence, file ddc633e4-5abb-4e2e-e053-3705fe0a4c80 44
Nutrition in patients with cancer: A new area for medical oncologists? A practising oncologist's interdisciplinary position paper, file ddc633e4-608b-4e2e-e053-3705fe0a4c80 39
Rationale and budget impact of bimonthly use of Cetuximab in patients with recurrent and/or metastatic head and neck cancer, file ddc633e4-5cc4-4e2e-e053-3705fe0a4c80 37
What to do and what not to do in the management of cancer pain: A physician survey and expert recommendations, file ddc633e4-65b8-4e2e-e053-3705fe0a4c80 37
Prognostic Nutritional Index: An easy nutritional screening for patients with head and neck cancer?, file ddc633e4-5cc8-4e2e-e053-3705fe0a4c80 35
The role of benzydamine in prevention and treatment of chemoradiotherapy-induced mucositis, file ddc633e4-5e17-4e2e-e053-3705fe0a4c80 35
Editorial: Advances in the Multidisciplinary Management of Oral Cancer, file ddc633e4-5f85-4e2e-e053-3705fe0a4c80 34
Transformation of Cancer Care during and after the COVID Pandemic, a point of no return. The Experience of Italy, file ddc633e4-5fa4-4e2e-e053-3705fe0a4c80 33
Recurrent/metastatic squamous cell carcinoma of the head and neck: A big and intriguing challenge which may be resolved by integrated treatments combining locoregional and systemic therapies, file ddc633e4-6120-4e2e-e053-3705fe0a4c80 33
Abiraterone Acetate in Patients With Castration-Resistant, Androgen Receptor-Expressing Salivary Gland Cancer: A Phase II Trial, file ddc633e4-5c1f-4e2e-e053-3705fe0a4c80 32
Vitamin D supplementation and cancer mortality: Narrative review of observational studies and clinical trials, file ddc633e4-62b5-4e2e-e053-3705fe0a4c80 32
Overview of oral potentially malignant disorders: From risk factors to specific therapies, file ddc633e4-5cbe-4e2e-e053-3705fe0a4c80 31
The spectrum of malnutrition/cachexia/sarcopenia in oncology according to different cancer types and settings: A narrative review, file ddc633e4-5de8-4e2e-e053-3705fe0a4c80 30
The Burning Question: Prophylactic Gabapentin for Mucositis-Related Pain in Patients Undergoing Chemoradiation Therapy for Head and Neck Cancer?, file ddc633e4-6f59-4e2e-e053-3705fe0a4c80 30
Advanced lung cancer inflammation index and its prognostic value in HPV-negative head and neck squamous cell carcinoma: a multicentre study, file ddc633e4-5962-4e2e-e053-3705fe0a4c80 29
Immunotherapy in Underrepresented Populations of Patients with Cancer: Do We Have Enough Evidence at Present? A Focus on Patients with Major Viral Infections and Autoimmune Disorders, file ddc633e4-65f0-4e2e-e053-3705fe0a4c80 28
Not all hematopoietic growth factors are created equal: Should we gain information for their use with immunotherapy?, file ddc633e4-671d-4e2e-e053-3705fe0a4c80 25
Immunotherapy for Cutaneous Squamous Cell Carcinoma: Results and Perspectives, file ddc633e4-6fea-4e2e-e053-3705fe0a4c80 25
Malnutrition management in oncology: An expert view on controversial issues and future perspectives, file 850747bb-c850-48b6-95f1-ab45d705fc9d 23
Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial, file ddc633e4-4d0f-4e2e-e053-3705fe0a4c80 23
A randomized, double-blind, placebo-controlled, cross-over study to evaluate the efficacy of Aqualief™ mucoadhesive tablets in head and neck cancer patients who developed radiation-induced xerostomia, file ddc633e4-5afd-4e2e-e053-3705fe0a4c80 22
Immunotherapy in nonendemic nasopharyngeal carcinoma: Real-world data from two nonendemic regions, file ddc633e4-6f57-4e2e-e053-3705fe0a4c80 22
Salvage surgery in recurrent sinonasal cancers: Proposal for a prognostic model based on clinicopathologic and treatment-related parameters, file 2e2e90d3-50dc-42fa-91db-a3a833ae18f1 20
Effectiveness of a phone-based nurse monitoring assessment and intervention for chemotherapy-related toxicity: A randomized multicenter trial, file 7d17a536-56c5-466f-8e35-218df8b0aa67 20
New Challenges in Evaluating Outcomes after Immunotherapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma, file e3da00a3-4db0-4bb7-8f34-7efaf13d2c43 18
Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022, file 5323863e-3f58-415d-9746-557624e118e0 17
A European survey on the practice of nutritional interventions in head–neck cancer patients undergoing curative treatment with radio(chemo)therapy, file ddc633e4-671e-4e2e-e053-3705fe0a4c80 17
Refining Tumor Treatment in Sinonasal Cancer Using Delta Radiomics of Multi-Parametric MRI after the First Cycle of Induction Chemotherapy, file ddc633e4-6f5a-4e2e-e053-3705fe0a4c80 12
Different inflammatory blood markers correlate with specific outcomes in incident HPV-negative head and neck squamous cell carcinoma: a retrospective cohort study, file ddc633e4-6899-4e2e-e053-3705fe0a4c80 11
An Inflammatory Signature to Predict the Clinical Benefit of First-Line Cetuximab Plus Platinum-Based Chemotherapy in Recurrent/Metastatic Head and Neck Cancer, file 201a3d6b-e386-4233-b50a-988884fe08b7 9
Prognostic Nomograms in Oral Squamous Cell Carcinoma: The Negative Impact of Low Neutrophil to Lymphocyte Ratio, file ddc633e3-c6a5-4e2e-e053-3705fe0a4c80 9
Treatment of cutaneous squamous cell carcinoma with immune checkpoint inhibitors in special populations, file ddc633e4-683c-4e2e-e053-3705fe0a4c80 9
The Multidisciplinary Management of Cutaneous Squamous Cell Carcinoma: A Comprehensive Review and Clinical Recommendations by a Panel of Experts, file ddc633e4-686f-4e2e-e053-3705fe0a4c80 9
Treatment Stratification in First-Line Recurrent or Metastatic Head and Neck Cancer, on Behalf of the EORTC Young Investigator Head and Neck Cancer Group, file ddc633e4-6871-4e2e-e053-3705fe0a4c80 8
Confounding factors in the assessment of oral mucositis in head and neck cancer, file 011b68ab-350d-4b7a-8638-2793f828864f 7
Unmet Needs and Perspectives in Oral Cancer Prevention, file 93d19bdf-cd91-4e82-81c4-ca48d8b2cd93 7
Estimating survival after salvage surgery for recurrent salivary gland cancers: Systematic review, file a3dc087a-4417-4f8f-b8c1-37f0f387d243 7
Cytotoxic effects of targeted agent alone or with chemotherapy in the treatment of adenoid cystic carcinoma: a preclinical study, file eeac2dd5-94fb-4be9-965d-fbc3a99c1c85 7
Rapid-Onset Opioids for Management of Breakthrough Cancer Pain: Considerations for Daily Practice, file f44bc3e5-2328-484c-a51c-6557effdc03c 7
Corrigendum to "Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma" [Eur J Canc 157 (2021) 250-258], file 1f5ecf27-f99b-4ebf-8e0b-b012514f9a18 6
Clinical and Histological Prognostic Factors of Recurrence and Malignant Transformation in a Large Series of Oral Potentially Malignant Disorders, file 29427f2e-7f57-400f-b580-eb270926bb0e 6
Nationwide multidisciplinary consensus on the clinical management of Merkel cell carcinoma: a Delphi panel, file 995ba39f-2e7d-4e90-8563-8e83b79b019e 5
Vitamin D and SARS-CoV2 infection, severity and mortality: A systematic review and meta-analysis, file d1ec1fcb-8f36-4812-8c2e-c467a33cc70e 5
Nutritional Support in Cancer patients: update of the Italian Intersociety Working Group practical recommendations, file f09e45f2-e6ff-4777-9a65-004230649b7a 5
Personalized Medicine in Skull Base and Sinonasal Tumors, file 0854f2da-2613-414d-8a1c-7bf7e3920a2c 4
Treatment and outcome of metastatic parathyroid carcinoma: A systematic review and pooled analysis of published cases, file 95f34938-1541-4885-94b0-17738ca8073c 4
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement, file ddc633e3-25d0-4e2e-e053-3705fe0a4c80 4
Functional profiles of curatively treated adenoid cystic carcinoma unveil prognostic features and potentially targetable pathways, file b4e7aafa-3eb1-4246-aa8c-838f56f663d1 2
Cetuximab in the management of nasopharyngeal carcinoma - A narrative review, file ddc633e4-6514-4e2e-e053-3705fe0a4c80 2
Comparison of platinum-based regimens in combination with radiotherapy for head and neck cancers: A network meta-analysis, file 94f0d825-06ce-4a6c-980b-72ec9fb89f63 1
Treatment de-escalation for HPV+ oropharyngeal cancer: A systematic review and meta-analysis, file 99b221ec-dd08-4a52-8de7-935fe59bf332 1
Predictors of Patient-Reported Dysphagia Following IMRT Plus Chemotherapy in Oropharyngeal Cancer, file ddc633e3-c0b3-4e2e-e053-3705fe0a4c80 1
Management of sinonasal adenocarcinomas with anterior skull base extension, file ddc633e4-59ba-4e2e-e053-3705fe0a4c80 1
Sinonasal cancers treatments: state of the art, file ddc633e4-59d8-4e2e-e053-3705fe0a4c80 1
Nasopharyngeal cancer in non-endemic areas: Impact of treatment intensity within a large retrospective multicentre cohort, file ddc633e4-5aa5-4e2e-e053-3705fe0a4c80 1
Impact of treatment expertise on the outcome of patients with head and neck cancer treated within 6 randomized trials, file ddc633e4-5cc6-4e2e-e053-3705fe0a4c80 1
In Reply to Fakhry et al, file ddc633e4-5cca-4e2e-e053-3705fe0a4c80 1
Immunonutrition in head and neck cancer patients undergoing chemoradiotherapy: An alternative approach for overcoming potential bias, file ddc633e4-5d3e-4e2e-e053-3705fe0a4c80 1
Prognostic role of pre-treatment magnetic resonance imaging (MRI)-based radiomic analysis in effectively cured head and neck squamous cell carcinoma (HNSCC) patients, file ddc633e4-5d40-4e2e-e053-3705fe0a4c80 1
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation, file ddc633e4-5d67-4e2e-e053-3705fe0a4c80 1
The pathogenesis of mucositis: updated perspectives and emerging targets, file ddc633e4-5d6c-4e2e-e053-3705fe0a4c80 1
Gene signatures and expression of miRNAs associated with efficacy of panitumumab in a head and neck cancer phase II trial, file ddc633e4-5e22-4e2e-e053-3705fe0a4c80 1
Multivariable model for predicting acute oral mucositis during combined IMRT and chemotherapy for locally advanced nasopharyngeal cancer patients, file ddc633e4-5f37-4e2e-e053-3705fe0a4c80 1
Malignant salivary gland tumours in families with breast cancer susceptibility, file ddc633e4-6075-4e2e-e053-3705fe0a4c80 1
Survival and toxicity of weekly cisplatin chemoradiotherapy versus three-weekly cisplatin chemoradiotherapy for head and neck cancer: A systematic review and meta-analysis endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO), file ddc633e4-615b-4e2e-e053-3705fe0a4c80 1
M. D. Anderson symptom inventory head neck (MDASI-HN) questionnaire: Italian language psychometric validation in head and neck cancer patients treated with radiotherapy ± systemic therapy – A study of the Italian Association of Radiotherapy and Clinical Oncology (AIRO), file ddc633e4-615d-4e2e-e053-3705fe0a4c80 1
Fatigue, a major still underestimated issue, file ddc633e4-6192-4e2e-e053-3705fe0a4c80 1
Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer, file ddc633e4-6242-4e2e-e053-3705fe0a4c80 1
Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma, file ddc633e4-62b7-4e2e-e053-3705fe0a4c80 1
Precision medicine in rare tumors and the need for multicenter trials and international collaboratives: Sinonasal cancer as paradigm, file ddc633e4-64a4-4e2e-e053-3705fe0a4c80 1
Systematic review of growth factors and cytokines for the management of oral mucositis in cancer patients and clinical practice guidelines, file ddc633e4-6512-4e2e-e053-3705fe0a4c80 1
Baseline prognostic factors affecting survival in recurrent and/or metastatic salivary gland adenoid cystic carcinoma, file ddc633e4-6ec7-4e2e-e053-3705fe0a4c80 1
Totale 7194
Categoria #
all - tutte 13726
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13726

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192 0000 00 00 0002
2019/2020302 5243431 1511 2517 23442647
2020/20211645 96176148114 117148 119133 165120136173
2021/20222777 104120112332 279176 184154 247171519379
2022/20232469 233159452229 147224 174172 19324820632
Totale 7195